Bristol Myers Squibb Receives European Commission Approval for Opdivo October 22, 2021 Auto Bot News 0 The EC approved BMS’s Opdivo (nivolumab) as a complementary treatment to chemotherapy for adult patients with certain types of gastric or esophageal cancer.